Actively Recruiting
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
Led by Taichung Veterans General Hospital · Updated on 2026-01-29
250
Participants Needed
2
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.
CONDITIONS
Official Title
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 20 years and older.
- Diagnosed with colorectal cancer.
- Started anti-cancer therapies between January 1, 2020, and April 30, 2024.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Chung-Shan Medical University Hospital
Taichung, Taiwan
Not Yet Recruiting
2
Taichung Veterans General Hospital
Taichung, Taiwan
Actively Recruiting
Research Team
C
Chou-Chen Chen, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here